Copy-number variants in patients with a strong family history of pancreatic cancer

Robert Lucito, Shubha Suresh, Kimberly Walter, Akhilesh Pandey, B. Lakshmi, Alex Krasnitz, Jonathan Sebat, Michael Wigler, Alison P. Klein, Kieran Brune, Emily Palmisano, Anirban Maitra, Michael Goggins, Ralph H. Hruban

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Copy-number variants such as germ-line deletions and amplifications are associated with inherited genetic disorders including familial cancer. The gene or genes responsible for the majority of familial clustering of pancreatic cancer have not been identified. We used representational oligonucleotide microarray analysis (ROMA) to characterize germ-line copy number variants in 60 cancer patients from 57 familial pancreatic cancer kindreds. Fifty-seven of the 60 patients had pancreatic cancer and three had nonpancreatic cancers (breast, ovary, ovary). A familial pancreatic cancer kindred was defined as a kindred in which at least two first-degree relatives have been diagnosed with pancreatic cancer. Copy-number variants identified in 607 individuals without pancreatic cancer were excluded from further analysis. A total of 56 unique genomic regions with copy-number variants not present in controls were identified, including 31 amplifications and 25 deletions. Two deleted regions were observed in two different patients, and one in three patients. The germ-line amplifications had a mean size of 662 Kb, a median size of 379 Kb (range 8.2 Kb to 2.5 Mb) and included 425 known genes. Examples of genes included in the germ-line amplifications include the MAFK, JunD and BIRC6 genes. The germ-line deletions had a mean size of 375Kb, a median size 151 Kb (range 0.4 Kb to 2.3 Mb) and included 81 known genes. In multivariate analysis controlling for region size, deletions were 90% less likely to involve a gene than were duplications (p < 0.01). Examples of genes included in the germ-line deletions include the FHIT, PDZRN3 and ANKRD3 genes. Selected deletions and amplifications were confirmed using real-time PCR, including a germ-line amplification on chromosome 19. These genetic copy-number variants define potential candidate loci for the familial pancreatic cancer gene.

Original languageEnglish (US)
Pages (from-to)1592-1599
Number of pages8
JournalCancer Biology and Therapy
Volume6
Issue number10
DOIs
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Germ Cells
Genes
Chromosomes, Human, Pair 19
Inborn Genetic Diseases
Gene Duplication
Neoplasm Genes
Microarray Analysis
Oligonucleotide Array Sequence Analysis
Ovarian Neoplasms
Cluster Analysis
Real-Time Polymerase Chain Reaction
Ovary
Neoplasms
Multivariate Analysis
Breast Neoplasms

Keywords

  • Familial cancer
  • Germline amplifications
  • Germline deletions
  • Pancreatic cancer
  • Variants

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Lucito, R., Suresh, S., Walter, K., Pandey, A., Lakshmi, B., Krasnitz, A., ... Hruban, R. H. (2007). Copy-number variants in patients with a strong family history of pancreatic cancer. Cancer Biology and Therapy, 6(10), 1592-1599. https://doi.org/10.4161/cbt.6.10.4725

Copy-number variants in patients with a strong family history of pancreatic cancer. / Lucito, Robert; Suresh, Shubha; Walter, Kimberly; Pandey, Akhilesh; Lakshmi, B.; Krasnitz, Alex; Sebat, Jonathan; Wigler, Michael; Klein, Alison P.; Brune, Kieran; Palmisano, Emily; Maitra, Anirban; Goggins, Michael; Hruban, Ralph H.

In: Cancer Biology and Therapy, Vol. 6, No. 10, 01.01.2007, p. 1592-1599.

Research output: Contribution to journalArticle

Lucito, R, Suresh, S, Walter, K, Pandey, A, Lakshmi, B, Krasnitz, A, Sebat, J, Wigler, M, Klein, AP, Brune, K, Palmisano, E, Maitra, A, Goggins, M & Hruban, RH 2007, 'Copy-number variants in patients with a strong family history of pancreatic cancer', Cancer Biology and Therapy, vol. 6, no. 10, pp. 1592-1599. https://doi.org/10.4161/cbt.6.10.4725
Lucito, Robert ; Suresh, Shubha ; Walter, Kimberly ; Pandey, Akhilesh ; Lakshmi, B. ; Krasnitz, Alex ; Sebat, Jonathan ; Wigler, Michael ; Klein, Alison P. ; Brune, Kieran ; Palmisano, Emily ; Maitra, Anirban ; Goggins, Michael ; Hruban, Ralph H. / Copy-number variants in patients with a strong family history of pancreatic cancer. In: Cancer Biology and Therapy. 2007 ; Vol. 6, No. 10. pp. 1592-1599.
@article{4bec1e99e762459aa5f3ff38b8f78a9e,
title = "Copy-number variants in patients with a strong family history of pancreatic cancer",
abstract = "Copy-number variants such as germ-line deletions and amplifications are associated with inherited genetic disorders including familial cancer. The gene or genes responsible for the majority of familial clustering of pancreatic cancer have not been identified. We used representational oligonucleotide microarray analysis (ROMA) to characterize germ-line copy number variants in 60 cancer patients from 57 familial pancreatic cancer kindreds. Fifty-seven of the 60 patients had pancreatic cancer and three had nonpancreatic cancers (breast, ovary, ovary). A familial pancreatic cancer kindred was defined as a kindred in which at least two first-degree relatives have been diagnosed with pancreatic cancer. Copy-number variants identified in 607 individuals without pancreatic cancer were excluded from further analysis. A total of 56 unique genomic regions with copy-number variants not present in controls were identified, including 31 amplifications and 25 deletions. Two deleted regions were observed in two different patients, and one in three patients. The germ-line amplifications had a mean size of 662 Kb, a median size of 379 Kb (range 8.2 Kb to 2.5 Mb) and included 425 known genes. Examples of genes included in the germ-line amplifications include the MAFK, JunD and BIRC6 genes. The germ-line deletions had a mean size of 375Kb, a median size 151 Kb (range 0.4 Kb to 2.3 Mb) and included 81 known genes. In multivariate analysis controlling for region size, deletions were 90{\%} less likely to involve a gene than were duplications (p < 0.01). Examples of genes included in the germ-line deletions include the FHIT, PDZRN3 and ANKRD3 genes. Selected deletions and amplifications were confirmed using real-time PCR, including a germ-line amplification on chromosome 19. These genetic copy-number variants define potential candidate loci for the familial pancreatic cancer gene.",
keywords = "Familial cancer, Germline amplifications, Germline deletions, Pancreatic cancer, Variants",
author = "Robert Lucito and Shubha Suresh and Kimberly Walter and Akhilesh Pandey and B. Lakshmi and Alex Krasnitz and Jonathan Sebat and Michael Wigler and Klein, {Alison P.} and Kieran Brune and Emily Palmisano and Anirban Maitra and Michael Goggins and Hruban, {Ralph H.}",
year = "2007",
month = "1",
day = "1",
doi = "10.4161/cbt.6.10.4725",
language = "English (US)",
volume = "6",
pages = "1592--1599",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "10",

}

TY - JOUR

T1 - Copy-number variants in patients with a strong family history of pancreatic cancer

AU - Lucito, Robert

AU - Suresh, Shubha

AU - Walter, Kimberly

AU - Pandey, Akhilesh

AU - Lakshmi, B.

AU - Krasnitz, Alex

AU - Sebat, Jonathan

AU - Wigler, Michael

AU - Klein, Alison P.

AU - Brune, Kieran

AU - Palmisano, Emily

AU - Maitra, Anirban

AU - Goggins, Michael

AU - Hruban, Ralph H.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Copy-number variants such as germ-line deletions and amplifications are associated with inherited genetic disorders including familial cancer. The gene or genes responsible for the majority of familial clustering of pancreatic cancer have not been identified. We used representational oligonucleotide microarray analysis (ROMA) to characterize germ-line copy number variants in 60 cancer patients from 57 familial pancreatic cancer kindreds. Fifty-seven of the 60 patients had pancreatic cancer and three had nonpancreatic cancers (breast, ovary, ovary). A familial pancreatic cancer kindred was defined as a kindred in which at least two first-degree relatives have been diagnosed with pancreatic cancer. Copy-number variants identified in 607 individuals without pancreatic cancer were excluded from further analysis. A total of 56 unique genomic regions with copy-number variants not present in controls were identified, including 31 amplifications and 25 deletions. Two deleted regions were observed in two different patients, and one in three patients. The germ-line amplifications had a mean size of 662 Kb, a median size of 379 Kb (range 8.2 Kb to 2.5 Mb) and included 425 known genes. Examples of genes included in the germ-line amplifications include the MAFK, JunD and BIRC6 genes. The germ-line deletions had a mean size of 375Kb, a median size 151 Kb (range 0.4 Kb to 2.3 Mb) and included 81 known genes. In multivariate analysis controlling for region size, deletions were 90% less likely to involve a gene than were duplications (p < 0.01). Examples of genes included in the germ-line deletions include the FHIT, PDZRN3 and ANKRD3 genes. Selected deletions and amplifications were confirmed using real-time PCR, including a germ-line amplification on chromosome 19. These genetic copy-number variants define potential candidate loci for the familial pancreatic cancer gene.

AB - Copy-number variants such as germ-line deletions and amplifications are associated with inherited genetic disorders including familial cancer. The gene or genes responsible for the majority of familial clustering of pancreatic cancer have not been identified. We used representational oligonucleotide microarray analysis (ROMA) to characterize germ-line copy number variants in 60 cancer patients from 57 familial pancreatic cancer kindreds. Fifty-seven of the 60 patients had pancreatic cancer and three had nonpancreatic cancers (breast, ovary, ovary). A familial pancreatic cancer kindred was defined as a kindred in which at least two first-degree relatives have been diagnosed with pancreatic cancer. Copy-number variants identified in 607 individuals without pancreatic cancer were excluded from further analysis. A total of 56 unique genomic regions with copy-number variants not present in controls were identified, including 31 amplifications and 25 deletions. Two deleted regions were observed in two different patients, and one in three patients. The germ-line amplifications had a mean size of 662 Kb, a median size of 379 Kb (range 8.2 Kb to 2.5 Mb) and included 425 known genes. Examples of genes included in the germ-line amplifications include the MAFK, JunD and BIRC6 genes. The germ-line deletions had a mean size of 375Kb, a median size 151 Kb (range 0.4 Kb to 2.3 Mb) and included 81 known genes. In multivariate analysis controlling for region size, deletions were 90% less likely to involve a gene than were duplications (p < 0.01). Examples of genes included in the germ-line deletions include the FHIT, PDZRN3 and ANKRD3 genes. Selected deletions and amplifications were confirmed using real-time PCR, including a germ-line amplification on chromosome 19. These genetic copy-number variants define potential candidate loci for the familial pancreatic cancer gene.

KW - Familial cancer

KW - Germline amplifications

KW - Germline deletions

KW - Pancreatic cancer

KW - Variants

UR - http://www.scopus.com/inward/record.url?scp=41649088291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649088291&partnerID=8YFLogxK

U2 - 10.4161/cbt.6.10.4725

DO - 10.4161/cbt.6.10.4725

M3 - Article

C2 - 17912030

AN - SCOPUS:41649088291

VL - 6

SP - 1592

EP - 1599

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 10

ER -